series-a
Stage
1
Investors
About
Rarity Bioscience develops ultra-sensitive multiplex assays for mutation detection in blood and other liquid biopsies, utilizing its proprietary superRCA technology based on padlock probes and rolling circle amplification, enabling high-precision genetic analysis for research and clinical applications.
Explore Rarity Bioscience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.